Ambassadors from more than 60 countries are visiting Hyderabad-based leading cement company – Bharat Biotech and Biology E – to boost global interest in India’s vaccine development program against coronavirus. This is the first such initiative. This is what happened over a month ago when the Foreign Ministry briefed heads of more than 190 diplomatic missions and major international organizations on Corona-related matters.
Official sources said the visit was organized as part of the Foreign Ministry’s Kovid-19 initiative. He said vaccine-related facilities will be visited in other cities after the tour. India is making a significant contribution to global efforts against Kovid-19 and is increasingly interested in India’s vaccine development efforts, a source said.
Telangana: 64 foreign diplomats have arrived at Bharat Biotech in Hyderabad for the continuation of the briefing given by the Foreign Ministry (MEA). # COVID-19 pic.twitter.com/CxgtcEfgA8
– ANI (@ANI) December 9, 2020
India is the world’s largest vaccine maker and is a significant contributor to global efforts against the COVID 19 epidemic.
Prime Minister Narendra Modi said India’s vaccine production and distribution capability will be used to fight the crisis. Visit to conduct a comprehensive review of the production process.
On November 30, he was inducted into Genoa Bio Pharmaceuticals Limited, Zivic E Ltd Hyderabad and Dr. Reddy’s Laboratories Ltd. met with Hyderabad teams. The three teams are working on the development and preparation of the COVID-19 vaccine.
Bharat Biotech on Monday applied to the Drugs Controller General of India (DCGI) for emergency use of the locally developed COVID-19 vaccine ‘Kovaccine’. This is the second Indian company to apply for emergency use after the University of Oxford and AstraZeneca applied for such a vaccine, the Serum Institute of India.
.
